肺動脈性高血圧症（PAH）患者を対象としたソタテルセプト（MK-7962）の臨床試験（MK-7962-024）

基本情報

NCT ID

NCT06664801

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

164

治験依頼者名

Merck Sharp & Dohme LLC

概要

Researchers are looking for other ways to treat people with PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow to the lungs. The goal of the study is to learn: * What happens to different doses of sotatercept in a person's body over time when it is given using weight-banded doses compared to weight-based doses. There may be differences in how the medicine works with the new dosing method (weight-banded dosing) being studied in this trial. * About the safety of sotatercept and if people tolerate it

対象疾患

介入

依頼者（Sponsor）

実施施設 (6)